# FDA recall Z-0923-2021

> **Becton Dickinson & Company** · Class II · device recall initiated 2020-12-09.

## Product

BD Stimex Insulated Needle 22G x 2.13in ( 50 units/cs.) Indicated for administration of medications to affect anesthesia or analgesia to a specific anatomical location (region).  Catalog No. 404204

## Reason for recall

BD was advised by the European Notified Body, NSAI, that the instructions for use (IFU) needs to be updated to include the general contraindications

## Distribution

Alabama, Connecticut, Florida, Illinois, Indiana, Michigan, Missouri, Mississippi, North Carolina, Nebraska, Nevada, New York, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Virginia.    Foreign: Australia, Canada, Belgium and Singapore

## Key facts

- **Recall number:** Z-0923-2021
- **Recalling firm:** Becton Dickinson & Company
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2020-12-09
- **Report date:** 2021-02-03
- **Termination date:** 2022-08-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Franklin Lakes, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0923-2021

## Citation

> AI Analytics. FDA recall Z-0923-2021. Retrieved 2026-09-03 from https://api.ai-analytics.org/recall/Z-0923-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*